Impact Biomedical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 8

Employees

  • Stock Symbol
  • IBO

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $6.17
  • (As of Tuesday Closing)

Impact Biomedical General Information

Description

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1400 Broadfield Boulevard
  • Suite 130
  • Houston, TX 77084
  • United States
+1 (281)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Stock Exchange
ASE
Vertical(s)
Corporate Office
  • 1400 Broadfield Boulevard
  • Suite 130
  • Houston, TX 77084
  • United States
+1 (281)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impact Biomedical Stock Performance

As of 17-Nov-2026, Impact Biomedical’s stock price is $6.17. Its current market cap is $53.3M with 8.64M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.17 $4.91 $2.43 - $10.47 $53.3M 8.64M 17.9K $12.73

Impact Biomedical Financials Summary

As of 30-Sep-2026, Impact Biomedical has a trailing 12-month revenue of $38K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 51,081 78,719 25,082
Revenue 38 32 0 0
EBITDA 152 (12,525) (22,566) (2,856)
Net Income 1,613 (11,838) (24,708) (4,336)
Total Assets 16,427 17,405 20,290 44,633
Total Debt 0 0 8,878 12,074
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Impact Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impact Biomedical‘s full profile, request access.

Request a free trial

Impact Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurolog
Drug Discovery
Houston, TX
8 As of 2025

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Impact Biomedical Competitors (1)

One of Impact Biomedical’s competitors is Applied Biological Laboratories, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Applied Biological Laboratories Venture Capital-Backed New York, NY
You’re viewing 1 of 1 competitors. Get the full list »

Impact Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impact Biomedical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Impact Biomedical‘s full profile, request access.

Request a free trial

Impact Biomedical Acquisitions (3)

Impact Biomedical’s most recent deal was a Reverse Merger with Zoar (Pharmaceuticals). The deal was made on 16-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zoar (Pharmaceuticals) 16-Sep-2026 Reverse Merger Pharmaceuticals
Document Security Systems (Celios Air Purification) 25-Feb-2025 Merger/Acquisition Electrical Equipment
Sweet Sense 08-Nov-2019 Merger/Acquisition Food Products
To view Impact Biomedical’s complete acquisitions history, request access »

Impact Biomedical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Impact Biomedical’s complete esg history, request access »

Impact Biomedical FAQs

  • When was Impact Biomedical founded?

    Impact Biomedical was founded in 2018.

  • Where is Impact Biomedical headquartered?

    Impact Biomedical is headquartered in Houston, TX.

  • What is the size of Impact Biomedical?

    Impact Biomedical has 8 total employees.

  • What industry is Impact Biomedical in?

    Impact Biomedical’s primary industry is Drug Discovery.

  • Is Impact Biomedical a private or public company?

    Impact Biomedical is a Public company.

  • What is Impact Biomedical’s stock symbol?

    The ticker symbol for Impact Biomedical is IBO.

  • What is the current stock price of Impact Biomedical?

    As of 17-Nov-2026 the stock price of Impact Biomedical is $6.17.

  • What is the current market cap of Impact Biomedical?

    The current market capitalization of Impact Biomedical is $53.3M.

  • What is Impact Biomedical’s current revenue?

    The trailing twelve month revenue for Impact Biomedical is $38K.

  • Who are Impact Biomedical’s competitors?

    Applied Biological Laboratories is a competitor of Impact Biomedical.

  • What is Impact Biomedical’s annual earnings per share (EPS)?

    Impact Biomedical’s EPS for 12 months was $12.73.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process